Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Impact of a Pediatric Sickle Cell Outpatient Pain Clinic on Health Outcomes

Raven Myrick, MSN, CRNP, Brandi Pernell, DNP, Avi Madan-Swain, PhD, Thomas H. Howard, MD, Lee Hilliard, MD, Jeffrey D. Lebensburger, DO, MSPH

Blood (2019) 134 (Supplement_1): 4691.

https://doi.org/10.1182/blood-2019-131059

Published: 2019

Journal Articles

Retrospective Study of Patients with Upper Extremity Clots Presenting to Emergency Departments in Tertiary Care Hospitals in a Major Canadian City in the Last Five Years

Tania Pannu, MD, Eric Herget, MD, Deepa Suryanarayan, MBBS

Blood (2019) 134 (Supplement_1): 1163.

https://doi.org/10.1182/blood-2019-131497

Published: 2019

Journal Articles

National Trends in Leukemia Related Emergency Department Visits, Health Care Burden and Disposition Rate in the United States, 2010-2014

Mohamed Mokhtar Bakr, MD, Umar Zahid, MD MPH, Pavan Tenneti, MD, Alsadiq Waleed Al-Hillan, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 4695.

https://doi.org/10.1182/blood-2018-99-117879

Published: 2018

Journal Articles

Survivorship in WM: Identification of Factors Associated with Survival of More Than a Decade and with Early WM-Related Death

Blood (2016) 128 (22): 2954.

https://doi.org/10.1182/blood.V128.22.2954.2954

Published: 2016

Journal Articles

A Phase 1b Study of Vadastuximab Talirine As Maintenance and in Combination with Standard Consolidation for Patients with Acute Myeloid Leukemia (AML)

Jay Yang, MD, Farhad Ravandi, MD, Anjali Advani, MD, Sumithira Vasu, MBBS, Roland B. Walter, MD PhD, Stefan Faderl, MD, Anthony S. Stein, MD, Harry P. Erba, MD PhD, Amir T. Fathi, MD, William B. Donnellan, MD, Moshe Y Levy, MD, Scott E. Smith, MD PhD, Brent L. Wood, MD PhD, Eric J. Feldman, MD, Jenna L Voellinger, PhD, Michael B. Maris, MD

Blood (2016) 128 (22): 340.

https://doi.org/10.1182/blood.V128.22.340.340

Published: 2016

Journal Articles

Metabolic Profiling of Adult Acute Myeloid Leukemia (AML)

Blood (2016) 128 (22): 1684.

https://doi.org/10.1182/blood.V128.22.1684.1684

Published: 2016

Journal Articles

Comparison of Disposition and Complications in Geriatric (≥ 65 years) and Non-Geriatric (50-64 years) Cancer Patients Receiving Hematopoietic Stem Cell Transplantation

Achuta Kumar Guddati, MD PhD, Gagan Kumar, MD MS, Robert David Lewis, MD, Iuliana Shapira, MD

Blood (2016) 128 (22): 2408.

https://doi.org/10.1182/blood.V128.22.2408.2408

Published: 2016

Journal Articles

Pharmacokinetics and Excretion of 14C-Labeled Polyethylene Glycol (60 kDa) in Rats

Andreas Baumann, Thomas Schwarz, Dietrich Seidel, Frank Hucke, Wolfram Steinke, Klaus Buehner

Blood (2014) 124 (21): 1473.

https://doi.org/10.1182/blood.V124.21.1473.1473

Published: 2014

Journal Articles

Metabolism and Disposition of Betrixaban and Its Lack of Interaction with Major CYP Enzymes.

Athiwat Hutchaleelaha, Ph.D., Christine Ye, Ph.D., Yonghong Song, Ph.D., Todd Lorenz, MD, Daniel Gretler, MD, Joseph L Lambing, Ph.D.

Blood (2012) 120 (21): 2266.

https://doi.org/10.1182/blood.V120.21.2266.2266

Published: 2012

Journal Articles

SLCO1B1 Variation and Methotrexate Disposition in Children with Acute Lymphoblastic Leukemia: The Importance of Rare Variants in Pharmacogenetics

Laura B. Ramsey, PhD, Gitte H Bruun, Wenjian Yang, PhD, Lisa R Trevino, PhD, Selina Vattathil, Paul Scheet, PhD, Cheng Cheng, PhD, Gary Rosner, Kathleen Giacomini, PhD, Yiping Fan, PhD, Alex Sparreboom, PhD, Torben Mikkelsen, MD PhD, Thomas J Corydon, PhD, Ching-Hon Pui, MD, William E. Evans, PharmD, Mary V. Relling, PharmD

Blood (2011) 118 (21): 571.

https://doi.org/10.1182/blood.V118.21.571.571

Published: 2011

Journal Articles

Phase I Study of RO5072759 (GA101) in Patients with Relapsed/Refractory CD20+ Non-Hodgkin Lymphoma (NHL).

Gilles Salles, MD, PhD, Franck Morschhauser, MD, PhD, Thierry Lamy, MD, PhD, Noel Milpied, MD, PhD, Catherine Thieblemont, MD, PhD, Herve Tilly, MD, Gabi Bieska, MSc, David Carlile, PhD, Guillaume Cartron, MD, PhD

Blood (2009) 114 (22): 1704.

https://doi.org/10.1182/blood.V114.22.1704.1704

Published: 2009

Journal Articles

Phase I Study of RO5072759 (GA101) in Relapsed/Refractory Chronic Lymphocytic Leukemia.

Franck Morschhauser, MD, PhD, Guillaume Cartron, MD, Thierry Lamy, MD, PhD, Noel-Jean Milpied, MD, PhD, Catherine Thieblemont, MD, PhD, Hervé Tilly, M.D., Martin Weisser, MD, Joe Birkett, Ph.D., Gilles Andre Salles, MD, PhD

Blood (2009) 114 (22): 884.

https://doi.org/10.1182/blood.V114.22.884.884

Published: 2009

Journal Articles

Differing Clot Distribution in Black Compared to White Patients Presenting with Acute Lower Extremity Deep Venous Thrombosis

Tyler W Buckner, MD, Soham Puvvada, MD, Chirag Amin, MD, Nigel S. Key, MBChB

Blood (2008) 112 (11): 3819.

https://doi.org/10.1182/blood.V112.11.3819.3819

Published: 2008

Journal Articles

Hospital Care of Pathological Vertebral Fracture (PVF) in Multiple Myeloma (MM) Patients: Burden of Illness and Patterns of Care

Jeffrey Alan Jones, MD, MPH, John C. Byrd, MD, Joseph M Flynn, DO, MPH, Craig Hofmeister, MD

Blood (2008) 112 (11): 2409.

https://doi.org/10.1182/blood.V112.11.2409.2409

Published: 2008

Journal Articles

Metabolism, Disposition and Pharmacokinetics of PR-171, a Novel Inhibitor of the 20S Proteasome.

Jinfu Yang, PhD, Fabiana Fonseca, PhD, Mark Ho, BS, Christopher J. Kirk, PhD, Louis S. Sehl, PhD, Evan R. Lewis, PhD

Blood (2006) 108 (11): 5067.

https://doi.org/10.1182/blood.V108.11.5067.5067

Published: 2006

Journal Articles

Drug Metabolism and Disposition Genes in Israeli HIV Patients: MDR1 and CYP3A4 Polymorphisms May Affect Susceptibility to HIV but Not the Course of the Disease.

Meirav Kedmi, MD, Sara Bar Cohen, PhD, Michelle Hauzi, RN, Shlomo Maayan, MD, Deborah Rund, MD

Blood (2005) 106 (11): 1434.

https://doi.org/10.1182/blood.V106.11.1434.1434

Published: 2005

Journal Articles

Intravenous Busulfan: Pharmacokinetic Disposition and Clinical Outcomes in Children Undergoing Hematopoietic Stem Cell Transplant.

Tal Schechter, MD, Yaron Finkelstein, MD, John Doyle, MD, Zulfikaral Verjee, PhD, Gideon Koren, MD, Lee Dupuis, MScPhm

Blood (2005) 106 (11): 1760.

https://doi.org/10.1182/blood.V106.11.1760.1760

Published: 2005

Journal Articles

Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment

Gianluigi Zaza, Meyling Cheok, Wenjian Yang, John C. Panetta, Ching-Hon Pui, Mary V. Relling, William E. Evans

Blood (2005) 106 (5): 1778–1785.

https://doi.org/10.1182/blood-2005-01-0143

Published: 2005

Includes: Supplemental data

Journal Articles

Polymorphisms in Drug Metabolism/Disposition Genes and Increased Susceptibility to Adult De Novo AML: MDR1 and CYP3A4.

Meirav Kedmi, MD, Sara B. Cohen, PhD, Deborah Rund, MD

Blood (2004) 104 (11): 2078.

https://doi.org/10.1182/blood.V104.11.2078.2078

Published: 2004

Journal Articles

Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia

Shinji Kishi, Wenjian Yang, Benoit Boureau, Stanislas Morand, Soma Das, Peixian Chen, Edwin H. Cook, Gary L. Rosner, Erin Schuetz, Ching-Hon Pui, Mary V. Relling

Blood (2004) 103 (1): 67–72.

https://doi.org/10.1182/blood-2003-06-2105

Published: 2004

Includes: Supplemental data

NARROW

Impact of a Pediatric Sickle Cell Outpatient Pain Clinic on Health Outcomes

Retrospective Study of Patients with Upper Extremity Clots Presenting to Emergency Departments in Tertiary Care Hospitals in a Major Canadian City in the Last Five Years

National Trends in Leukemia Related Emergency Department Visits, Health Care Burden and Disposition Rate in the United States, 2010-2014

Survivorship in WM: Identification of Factors Associated with Survival of More Than a Decade and with Early WM-Related Death

A Phase 1b Study of Vadastuximab Talirine As Maintenance and in Combination with Standard Consolidation for Patients with Acute Myeloid Leukemia (AML)

Metabolic Profiling of Adult Acute Myeloid Leukemia (AML)

Comparison of Disposition and Complications in Geriatric (≥ 65 years) and Non-Geriatric (50-64 years) Cancer Patients Receiving Hematopoietic Stem Cell Transplantation

Pharmacokinetics and Excretion of 14C-Labeled Polyethylene Glycol (60 kDa) in Rats

Metabolism and Disposition of Betrixaban and Its Lack of Interaction with Major CYP Enzymes.

SLCO1B1 Variation and Methotrexate Disposition in Children with Acute Lymphoblastic Leukemia: The Importance of Rare Variants in Pharmacogenetics

Phase I Study of RO5072759 (GA101) in Patients with Relapsed/Refractory CD20+ Non-Hodgkin Lymphoma (NHL).

Phase I Study of RO5072759 (GA101) in Relapsed/Refractory Chronic Lymphocytic Leukemia.

Differing Clot Distribution in Black Compared to White Patients Presenting with Acute Lower Extremity Deep Venous Thrombosis

Hospital Care of Pathological Vertebral Fracture (PVF) in Multiple Myeloma (MM) Patients: Burden of Illness and Patterns of Care

Metabolism, Disposition and Pharmacokinetics of PR-171, a Novel Inhibitor of the 20S Proteasome.

Drug Metabolism and Disposition Genes in Israeli HIV Patients: MDR1 and CYP3A4 Polymorphisms May Affect Susceptibility to HIV but Not the Course of the Disease.

Intravenous Busulfan: Pharmacokinetic Disposition and Clinical Outcomes in Children Undergoing Hematopoietic Stem Cell Transplant.

Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment

Polymorphisms in Drug Metabolism/Disposition Genes and Increased Susceptibility to Adult De Novo AML: MDR1 and CYP3A4.

Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only